Zydus gets DCGI approval to commence Phase III clinical trials with Pegylated Interferon alpha-2b EP News Bureau Dec 4, 2020 In Phase II clinical trials, Pegylated Interferon alpha – 2b increased viral reduction and reduced the need for supplemental…
Zydus concludes Phase II trials of Pegylated Interferon alpha-2b for COVID-19, to begin Phase III… EP News Bureau Nov 12, 2020 In 19 out of 20 patients, a single 1 mcg/kg dose of the drug demonstrated viral clearance as assessed by RT-PCR and a significant…
